πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Disc Medicine Patents

Full USPTO pharma patent portfolio for Disc Medicine β€” grant dates, expiration, and drug cross-links.

Patents
706
Expiring ≀24m
26

Quick answer

Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months β€” use filters for patent-cliff planning.

Page 3 of 15

  1. US 11673899

    Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereof

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11673873

    Apelin receptor agonists and methods of use thereof

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11655248

    Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11648287

    Composition for the treatment of intracellular bacterial infection

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11649239

    Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11639355

    Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors

    Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11639364

    Potent sialyltransferase inhibitors

    Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11634424

    Diazaindole derivative and use thereof as CHK1 inhibitor

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11623923

    Uracil compound as c-MET/AXL inhibitor

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11617770

    Sporeforming probiotic strains, methods and uses thereof

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11612575

    Combination therapies with disulfiram

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11578081

    Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11571446

    Gut microbiota and treatment of cancer

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11572372

    Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11571484

    Compositions that target tumor-associated macrophages and methods of use therefor

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11571485

    Peptides and antibodies for detecting changes in alzheimer's disease brain and methods of use thereof

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11564937

    Nucleoporins as drug targets for anti-proliferative therapeutics

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11542275

    Substituted imidazolidin-2-one derivatives as PRMT5 inhibitors

    Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11534465

    Fecal matter for treatment of autoimmune diseases

    Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11512110

    Targeted delivery system and methods of use therefor

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11512060

    1,2,4-oxadiazole derivatives as immunomodulators

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11497734

    Dual inhibitors of TIM-3 and PD-1 pathways

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11497735

    Conjoint therapies for immunomodulation

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11491133

    Heteroaryl-isochroman compounds and uses thereof

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11465976

    1,2,4-oxadiazole and thiadiazole compounds as immunomodulators

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11465995

    Crystal and salt forms of tricyclic compound and preparation process thereof

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11466024

    Bicylic compound acting as an inhibitor

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11459323

    Monocyclic Ξ²-lactam compound for treating bacterial infection

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11458210

    Compounds and compositions for targeting brain injuries and methods of use thereof

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11453667

    Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11452717

    Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11447453

    Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11440939

    Anticancer peptides

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11439669

    C. novyi for the treatment of solid tumors in humans

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11433053

    LSD1 inhibitor and preparation method and application thereof

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11419875

    Compounds and compositions for treating hematological disorders

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11401286

    Heteroaryl inhibitors of PDE4

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11384065

    Heterocyclic compound as CSF-1R inhibitor and use thereof

    Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11377444

    Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11376303

    Compositions and methods for treating nervous system injuries

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11365221

    Compositions and methods for treating autoimmune and inflammatory disorders

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11365205

    Imidazolidin-2-one compounds as PRMT5 modulators

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11359195

    Method for identifying antibiotic targets

    Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11352331

    Crystal and salt of 4-(naphthalen-1-yl)-4H-1,2,4-triazole compound and preparation method therefor

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11352428

    Modulation of immune response using BTLA agonist antibodies

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11352432

    Antibodies specifically binding to human IL-1R7

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11352395

    Anticancer peptides

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11352389

    Treatment of haematological malignancies

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Disc Medicine have?

706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Disc Medicine patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.